#rare-diseases

REGENXBIO Inc. (RGNX) Discusses Clinical Program Progress and Commercial Outlook in Wet AMD and Rare Diseases Transcript

REGENXBIO Inc. provided an update on its clinical programs for Wet Age-related Macular Degeneration (AMD) and rare diseases. The company also discussed its commercial outlook.